Vivani Medical is developing an implant of semaglutide, the active ingredient in Novo Nordisk's obesity injection Wegovy and ...

Medicare's upcoming weight-loss drug program could create major bottlenecks for doctors as millions of seniors seek access to popular GLP-1 treatments such as Wegovy and Zepbound. Clinicians are ...

Eli Lilly’s retatrutide has crossed the 30% weight loss benchmark in some patients. Where do GLP-1RAs go from here?

A pioneering food additive that can stop people from gaining weight has appeared on the EU's Novel Food List, indicating its ...

It isn't approved by the FDA, but we found an experimental weight-loss drug called retatrutide for sale at a local ...

An investigation uncovers a rapidly growing, highly lucrative shadow market in South Africa for unapproved weight-loss drugs ...

Equity Insider News Commentary, The weight-loss drug boom is one of the defining medical stories of the decade, and its ...

The Trump administration will launch its pilot program on Wednesday. It lasts 18 months, and estimated costs to taxpayers ...

Thousands of older Oregonians could soon pay just $50 a month for popular weight loss drugs that have previously been out of reach because of their price. Starting July 1, Medicare will launch a pilot ...

Medicare will start the GLP-1 Bridge program July 1. Older adults who qualify for the weight-loss drugs will pay a monthly ...

Bold's approach promotes muscle preservation and quality weight loss by pairing medication with comprehensive lifestyle support. As part of CMS' Bridge program, Bold will only pre ...

A White House spokesperson flipped out Tuesday after he was quoted failing to deny a report suggesting President Donald Trump may have been given early access to a weight loss drug. A STAT report ...